Literature DB >> 18094730

Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.

Ilana Chefetz1, Danny Ben Amitai, Sarah Browning, Karl Skorecki, Noam Adir, Mark G Thomas, Larissa Kogleck, Orit Topaz, Margarita Indelman, Jouni Uitto, Gabriele Richard, Neil Bradman, Eli Sprecher.   

Abstract

Normophosphatemic familial tumoral calcinosis (NFTC) is an autosomal recessive disorder characterized by calcium deposition in skin and mucosae and associated with unremitting pain and life-threatening skin infections. A homozygous missense mutation (p.K1495E), resulting in SAMD9 protein degradation, was recently shown to cause NFTC in five families of Jewish-Yemenite origin. In this study, we evaluated another Jewish-Yemenite NFTC kindred. All patients were compound heterozygous for two mutations in SAMD9: K1495E and a previously unreported nonsense mutation, R344X, predicted to result in a markedly truncated molecule. Screening of unaffected population-matched controls revealed heterozygosity for K1495E and R344X only in individuals of Jewish-Yemenite ancestry, but not in more than 700 control samples of other origins, including 93 non-Jewish Yemenite. These data may be suggestive of positive selection, considering the rarity of NFTC and the small size of the Jewish-Yemenite population; alternatively, they may reflect genetic drift or the effect of a population-specific modifier trait. Calcifications in NFTC generally develop over areas subjected to repeated trauma and are associated with marked inflammatory manifestations, indicating that SAMD9 may play a role in the inflammatory response to tissue injury. We therefore assessed the effect of cellular stress and tumor necrosis factor-alpha (TNF-alpha), a potent pro-inflammatory cytokine, on SAMD9 gene expression. Whereas exogenous hydrogen peroxide and heat shock did not affect SAMD9 transcription, osmotic shock was found to markedly upregulate SAMD9 expression. In addition, incubation of endothelial cells with TNF-alpha caused a dose-related, p38-dependant increase in SAMD9 expression. These data link NFTC and SAMD9 to the TNF-alpha signaling pathway, suggesting a role for this system in the regulation of extra-osseous calcification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094730      PMCID: PMC3169318          DOI: 10.1038/sj.jid.5701203

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  40 in total

1.  Two lessons from the interface of genetics and medicine.

Authors:  Anthony C Allison
Journal:  Genetics       Date:  2004-04       Impact factor: 4.562

2.  Tumoral calcinosis revisited--common and uncommon features. Report of ten cases and review.

Authors:  A Metzker; B Eisenstein; J Oren; R Samuel
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 3.  A genetic profile of contemporary Jewish populations.

Authors:  H Ostrer
Journal:  Nat Rev Genet       Date:  2001-11       Impact factor: 53.242

4.  Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.

Authors:  Shoji Ichikawa; Vincent Guigonis; Erik A Imel; Mélanie Courouble; Sophie Heissat; John D Henley; Andrea H Sorenson; Barbara Petit; Anne Lienhardt; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2007-02-20       Impact factor: 5.958

Review 5.  The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.

Authors:  Jeremy Saklatvala
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

Review 6.  Differential TNF-signaling in chronic inflammatory disorders.

Authors:  Martin H Holtmann; Markus F Neurath
Journal:  Curr Mol Med       Date:  2004-06       Impact factor: 2.222

7.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.

Authors:  Orit Topaz; Daniel L Shurman; Reuven Bergman; Margarita Indelman; Paulina Ratajczak; Mordechai Mizrachi; Ziad Khamaysi; Doron Behar; Dan Petronius; Vered Friedman; Israel Zelikovic; Sharon Raimer; Arieh Metzker; Gabriele Richard; Eli Sprecher
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

8.  Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol.

Authors:  Hao Cheng; Jürgen Kartenbeck; Kirsten Kabsch; Xiahong Mao; Margarita Marqués; Angel Alonso
Journal:  J Cell Physiol       Date:  2002-08       Impact factor: 6.384

9.  A single origin of phenylketonuria in Yemenite Jews.

Authors:  S Avigad; B E Cohen; S Bauer; G Schwartz; M Frydman; S L Woo; Y Niny; Y Shiloh
Journal:  Nature       Date:  1990-03-08       Impact factor: 49.962

10.  Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.

Authors:  Catherine F Li; Jeffrey R MacDonald; Robert Y Wei; Jocelyn Ray; Kimberly Lau; Christopher Kandel; Rachel Koffman; Sherilyn Bell; Stephen W Scherer; Benjamin A Alman
Journal:  BMC Genomics       Date:  2007-04-03       Impact factor: 3.969

View more
  38 in total

Review 1.  Disorders of phosphate homeostasis and tissue mineralisation.

Authors:  Clemens Bergwitz; Harald Jüppner
Journal:  Endocr Dev       Date:  2009-06-03

2.  An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function.

Authors:  Bernice Nounamo; Yibo Li; Peter O'Byrne; Aoife M Kearney; Amir Khan; Jia Liu
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

3.  The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.

Authors:  Qiujie Jiang; Benjamin Quaynor; Alex Sun; Qiaoli Li; Hirotaka Matsui; Hiroaki Honda; Toshiya Inaba; Eli Sprecher; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2011-03-17       Impact factor: 8.551

Review 4.  Mineralization/anti-mineralization networks in the skin and vascular connective tissues.

Authors:  Qiaoli Li; Jouni Uitto
Journal:  Am J Pathol       Date:  2013-05-08       Impact factor: 4.307

5.  Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.

Authors:  Q-Y Zuo; X Cao; B-Y Liu; D Yan; Z Xin; X-H Niu; C Li; W Deng; Z-Y Dong; J-K Yang
Journal:  J Endocrinol Invest       Date:  2019-09-18       Impact factor: 4.256

6.  Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype.

Authors:  Jay Sarthy; Ji Zha; Daria Babushok; Archana Shenoy; Jian-Meng Fan; Gerald Wertheim; Adam Himebauch; Ashley Munchel; Agne Taraseviciute; Samuel Yang; Hirohito Shima; Satoshi Narumi; Soheil Meshinchi; Timothy S Olson
Journal:  Blood Adv       Date:  2018-01-23

7.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

8.  Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.

Authors:  Qiaoli Li; Haitao Guo; Hirotaka Matsui; Hiroaki Honda; Toshiya Inaba; John P Sundberg; Eli Sprecher; Jouni Uitto
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

9.  Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.

Authors:  Eli Sprecher
Journal:  J Invest Dermatol       Date:  2009-10-29       Impact factor: 8.551

10.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7.

Authors:  Satoshi Narumi; Naoko Amano; Tomohiro Ishii; Noriyuki Katsumata; Koji Muroya; Masanori Adachi; Katsuaki Toyoshima; Yukichi Tanaka; Ryuji Fukuzawa; Kenichi Miyako; Saori Kinjo; Shouichi Ohga; Kenji Ihara; Hirosuke Inoue; Tadamune Kinjo; Toshiro Hara; Miyuki Kohno; Shiro Yamada; Hironaka Urano; Yosuke Kitagawa; Koji Tsugawa; Asumi Higa; Masakazu Miyawaki; Takahiro Okutani; Zenro Kizaki; Hiroyuki Hamada; Minako Kihara; Kentaro Shiga; Tetsuya Yamaguchi; Manabu Kenmochi; Hiroyuki Kitajima; Maki Fukami; Atsushi Shimizu; Jun Kudoh; Shinsuke Shibata; Hideyuki Okano; Noriko Miyake; Naomichi Matsumoto; Tomonobu Hasegawa
Journal:  Nat Genet       Date:  2016-05-16       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.